O-GlcNAc modification of FoxO1 increases its transcriptional activity: A role in the glucotoxicity phenomenon?
- 21 March 2008
- Vol. 90 (5) , 679-685
- https://doi.org/10.1016/j.biochi.2008.03.005
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O -GlcNAc in diabetes-associated erectile dysfunctionProceedings of the National Academy of Sciences, 2005
- O‐GlcNAc turns twenty: functional implications for post‐translational modification of nuclear and cytosolic proteins with a sugarFEBS Letters, 2003
- Altered glycan-dependent signaling induces insulin resistance and hyperleptinemiaProceedings of the National Academy of Sciences, 2002
- Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytesProceedings of the National Academy of Sciences, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt siteJournal of Clinical Investigation, 2001
- Glycan‐dependent signaling: O‐linked N‐acetylglucosamineThe FASEB Journal, 2001
- Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.Diabetes, 2000
- O-Glycosylation of Nuclear and Cytosolic ProteinsJournal of Biological Chemistry, 2000
- Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.Journal of Clinical Investigation, 1996